Ana
Rouzaut Subirá
Catedrática de Universidad
Publicacións nas que colabora con Ana Rouzaut Subirá (11)
2022
-
Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers
Theranostics, Vol. 12, Núm. 3, pp. 1373-1387
2021
-
Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophils
European Journal of Immunology, Vol. 51, Núm. 9, pp. 2274-2280
2020
-
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity
Immunity, Vol. 52, Núm. 5, pp. 856-871.e8
2018
-
Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) Costimulation
Cancer Immunology Research, Vol. 6, Núm. 7, pp. 798-811
2016
-
Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming
Cancer Research, Vol. 76, Núm. 20, pp. 5994-6005
2015
-
Functional expression of CD137 (4-1BB) on T helper follicular cells
OncoImmunology, Vol. 4, Núm. 12
2013
-
Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model
Clinical Cancer Research, Vol. 19, Núm. 22, pp. 6151-6162
-
Lymphatic endothelium forms integrin-engaging 3d structures during DC transit across inflamed lymphatic vessels
Journal of Investigative Dermatology, Vol. 133, Núm. 9, pp. 2276-2285
2011
-
Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes
Cancer Research, Vol. 71, Núm. 3, pp. 801-811
-
Intratumoral injection of interferon-α and systemic delivery of agonist anti-CD137 monoclonal antibodies synergize for immunotherapy
International Journal of Cancer, Vol. 128, Núm. 1, pp. 105-118
2008
-
Polly Matzinger's "danger model" finds its predicted danger-denoting self moieties
Inmunologia, Vol. 27, Núm. 4, pp. 205-211